Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2511-2516
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2511
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2511
Table 2 Serum endomysial and transglutaminase 2 antibody values, divided according to the clinical presentation
| EmA, titer | TG2-ab, U/L | |||
| Low 1:5-200 | High 1:≥500 | Low 5.0-29.9 | High≥30 | |
| n = 224, % | n = 154, % | n = 116, % | n = 166, % | |
| Abdominal symptoms | 45 | 40 | 45 | 45 |
| Anemia or malabsorption | 8 | 12 | 5 | 13 |
| Extraintestinal symptoms | 9 | 16 | 5 | 13 |
| Screen-detected subjects | 38 | 31 | 45 | 28 |
| P = 0.061 | P = 0.002 | |||
- Citation: Kurppa K, Räsänen T, Collin P, Iltanen S, Huhtala H, Ashorn M, Saavalainen P, Haimila K, Partanen J, Mäki M, Kaukinen K. Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation. World J Gastroenterol 2012; 18(20): 2511-2516
- URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2511.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i20.2511